157 related articles for article (PubMed ID: 12856363)
21. Gastrointestinal stromal tumours (Br J Surg 2003; 90: 1178-1186).
Amalesh T
Br J Surg; 2004 Feb; 91(2):252-3. PubMed ID: 14760677
[No Abstract] [Full Text] [Related]
22. [A step foward in the treatment of GIST].
Fattoruso SI; Lopez M
Clin Ter; 2008; 159(4):223-4. PubMed ID: 18776977
[No Abstract] [Full Text] [Related]
23. [Gastrointestinal stromal tumor].
Nishida T; Ohmori T; Matsuda H
Gan To Kagaku Ryoho; 2004 Mar; 31(3):331-6. PubMed ID: 15045935
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal stromal tumours.
Connolly EM; Gaffney E; Reynolds JV
Br J Surg; 2003 Oct; 90(10):1178-86. PubMed ID: 14515284
[TBL] [Abstract][Full Text] [Related]
25. [Diagnosis and conservative treatment of gastrointestinal stromal tumors (GIST)].
Büchner-Steudel P; Fleig WE
Dtsch Med Wochenschr; 2004 Aug; 129(34-35):1808-10. PubMed ID: 15314745
[No Abstract] [Full Text] [Related]
26. Five patients with malignant endocrine tumors treated with imatinib mesylate (Glivec).
Kindmark H; Janson ET; Gustavsson B; Eriksson C; Larsson G; Granberg D; Kozlowacki G; Skogseid B; Welin S; Oberg K; Eriksson B
Acta Oncol; 2010; 49(1):100-1. PubMed ID: 20100145
[No Abstract] [Full Text] [Related]
27. KIT/Val654 Ala receptor detected in one imatinib-resistant GIST patient.
Tamborini E; Gabanti E; Lagonigro MS; Negri T; Pilotti S; Pierotti MA; Pricl S
Cancer Res; 2005 Feb; 65(3):1115; author reply 1115. PubMed ID: 15705916
[No Abstract] [Full Text] [Related]
28. Pathological response of gastrointestinal stromal tumour to imatinib treatment correlates with tumour KIT mutational status in individual tumour clones.
Loughrey MB; Beshay V; Dobrovic A; Zalcberg J; Waring PM
Histopathology; 2006 Jul; 49(1):99-100. PubMed ID: 16842259
[No Abstract] [Full Text] [Related]
29. Not all c-kit mutations can be corrected by imatinib.
Lasota J
Lab Invest; 2007 Apr; 87(4):317. PubMed ID: 17486696
[No Abstract] [Full Text] [Related]
30. Targeting mutant kinases in gastrointestinal stromal tumors: a paradigm for molecular therapy of other sarcomas.
Heinrich MC; Corless CL
Cancer Treat Res; 2004; 120():129-50. PubMed ID: 15217222
[No Abstract] [Full Text] [Related]
31. Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study.
Verweij J; van Oosterom A; Blay JY; Judson I; Rodenhuis S; van der Graaf W; Radford J; Le Cesne A; Hogendoorn PC; di Paola ED; Brown M; Nielsen OS
Eur J Cancer; 2003 Sep; 39(14):2006-11. PubMed ID: 12957454
[TBL] [Abstract][Full Text] [Related]
32. Role of c-kit/SCF in cause and treatment of gastrointestinal stromal tumors (GIST).
Ali S; Ali S
Gene; 2007 Oct; 401(1-2):38-45. PubMed ID: 17659849
[TBL] [Abstract][Full Text] [Related]
33. [c-kit: an irresistible ascension from diagnostic marker to therapeutic].
Scoazec JY
Ann Pathol; 2002 Jun; 22(3):173-5. PubMed ID: 12410099
[No Abstract] [Full Text] [Related]
34. Soft-tissue sarcomas in adults.
Clark MA; Fisher C; Judson I; Thomas JM
N Engl J Med; 2005 Aug; 353(7):701-11. PubMed ID: 16107623
[No Abstract] [Full Text] [Related]
35. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 32-2004. A 68-year-old man with a large retroperitoneal mass.
Demetri GD; Titton RL; Ryan DP; Fletcher CD
N Engl J Med; 2004 Oct; 351(17):1779-87. PubMed ID: 15496628
[No Abstract] [Full Text] [Related]
36. Gastrointestinal stromal tumor: involvement in urologic patients and recent therapeutic advances.
Voelzke BB; Sakamoto K; Hantel A; Paner GP; Kash J; Waters WB; Campbell SC
Urology; 2002 Aug; 60(2):218-22. PubMed ID: 12137812
[No Abstract] [Full Text] [Related]
37. Merkel cell carcinoma: evaluation of KIT (CD117) expression and failure to demonstrate activating mutations in the C-KIT proto-oncogene - implications for treatment with imatinib mesylate.
Swick BL; Ravdel L; Fitzpatrick JE; Robinson WA
J Cutan Pathol; 2007 Apr; 34(4):324-9. PubMed ID: 17381803
[TBL] [Abstract][Full Text] [Related]
38. Is there a role for neoadjuvant treatment with Gleevec for large rectal gastrointestinal stromal tumors?
Wasserberg N; Nunoo-Mensah JW; Beart RW; Ker TS
Int J Colorectal Dis; 2007 Aug; 22(8):981-2. PubMed ID: 16583196
[No Abstract] [Full Text] [Related]
39. [Small-molecule inhibitors against KIT and PDGFRs especially in GISTs].
Shiba K; Matsumoto T; Hirota S
Gan To Kagaku Ryoho; 2009 Jul; 36(7):1080-5. PubMed ID: 19620796
[TBL] [Abstract][Full Text] [Related]
40. c-Kit/PDGFRA gene status alterations possibly related to primary imatinib resistance in gastrointestinal stromal tumors.
Miselli FC; Casieri P; Negri T; Orsenigo M; Lagonigro MS; Gronchi A; Fiore M; Casali PG; Bertulli R; Carbone A; Pierotti MA; Tamborini E; Pilotti S
Clin Cancer Res; 2007 Apr; 13(8):2369-77. PubMed ID: 17438095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
